A British trial of the AstraZeneca COVID-19 vaccine involving children has been paused over fears of a possible link to blood clots. Oxford University, who helped develop the vaccine, said in a statement: “Whilst there are no safety concerns in the paediatric clinical trial, we await additional information from the MHRA (UK regulator) on its… Read More »
An experimental medication that was recently shown to slow the progression of the neurodegenerative disease amyotrophic lateral sclerosis (ALS) has now demonstrated the potential to also prolong patient survival. The findings come from a clinical trial conducted by investigators at the Sean M. Healey & AMG Center for ALS at Harvard-afilliated Massachusetts General Hospital (MGH)… Read More »
Scientists are to test whether an experimental drug can prevent potentially deadly blood clots associated with Covid-19. The trial, funded by the British Heart Foundation, will test the theory the clots are caused by a hormone imbalance triggered by coronavirus infection. It will become one of several drugs currently being trialled to prevent the disease’s… Read More »
With megablockbuster Humira on the decline, AbbVie is hoping for big things from its next-gen JAK inhibitor Rinvoq. Now, in a head-to-head rheumatoid arthritis battle with Bristol Myers Squibb’s blockbuster Orencia, Rinvoq has come out on top. Rinvoq matched Bristol’s Orencia in easing rheumatoid arthritis patients’ symptoms at the 12-week mark and bested its older rival in patient remission rates, according to… Read More »